APO Research
Talk to an analyst

APO RESEARCH · REPORT

Angiotensin II Type 1 Receptor (AT1R) Antagonists

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Analysis and Forecast 2026-2032

26 December 2025197 pages

Choose your research edition.

Industry ResearchAngiotensin II Type 1 Receptor (AT1R) Antagonists Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Angiotensin II Type 1 Receptor (AT1R) Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Angiotensin II Type 1 Receptor (AT1R) Antagonists market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Angiotensin II Type 1 Receptor (AT1R) Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Angiotensin II Type 1 Receptor (AT1R) Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Angiotensin II Type 1 Receptor (AT1R) Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Angiotensin II Type 1 Receptor (AT1R) Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Angiotensin II Type 1 Receptor (AT1R) Antagonists include Takeda Pharmaceutical Co., Ltd., Shenzhen Salubris Pharmaceuticals Co., Ltd., Sanofi SA, Novartis, Merck, AbbVie, Inc., Cosette Pharmaceuticals, Inc. and Aurobindo Pharma Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Angiotensin II Type 1 Receptor (AT1R) Antagonists, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Angiotensin II Type 1 Receptor (AT1R) Antagonists, also provides the sales of main regions and countries. Of the upcoming market potential for Angiotensin II Type 1 Receptor (AT1R) Antagonists, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Angiotensin II Type 1 Receptor (AT1R) Antagonists sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Angiotensin II Type 1 Receptor (AT1R) Antagonists sales, projected growth trends, production technology, application and end-user industry.

Angiotensin II Type 1 Receptor (AT1R) Antagonists Segment by Company

Takeda Pharmaceutical Co., Ltd.

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Sanofi SA

Novartis

Merck

AbbVie, Inc.

Cosette Pharmaceuticals, Inc.

Aurobindo Pharma Ltd.

Angiotensin II Type 1 Receptor (AT1R) Antagonists Segment by Type

5mg

10mg

20mg

50mg

80mg

100mg

150mg

400mg

Angiotensin II Type 1 Receptor (AT1R) Antagonists Segment by Application

Hospital

Clinic

Others

Angiotensin II Type 1 Receptor (AT1R) Antagonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Angiotensin II Type 1 Receptor (AT1R) Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiotensin II Type 1 Receptor (AT1R) Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Angiotensin II Type 1 Receptor (AT1R) Antagonists in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Angiotensin II Type 1 Receptor (AT1R) Antagonists manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Angiotensin II Type 1 Receptor (AT1R) Antagonists sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5mg Major Manufacturers Table 3. 10mg Major Manufacturers Table 4. 20mg Major Manufacturers Table 5. 50mg Major Manufacturers Table 6. 80mg Major Manufacturers Table 7. 100mg Major Manufacturers Table 8. 150mg Major Manufacturers Table 9. 400mg Major Manufacturers Table 10. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 11. Hospital Major Manufacturers Table 12. Clinic Major Manufacturers Table 13. Others Major Manufacturers Table 14. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Trends Table 15. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Drivers Table 16. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Opportunities and Challenges Table 17. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Restraints Table 18. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Region (2021-2026) Table 22. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Region (2027-2032) Table 23. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 24. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region (2021-2026) & (K Units) Table 25. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region (2027-2032) & (K Units) Table 26. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Region (2021-2026) Table 27. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Region (2027-2032) Table 28. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Manufacturers (2021-2026) Table 32. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 33. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers, Product Type & Application Table 36. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type (2021-2026) Table 43. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type (2027-2032) Table 44. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 45. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2026) & (K Units) Table 46. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2027-2032) & (K Units) Table 47. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type (2021-2026) Table 48. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type (2027-2032) Table 49. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Type (2021-2026) & (US$/Unit) Table 50. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Type (2027-2032) & (US$/Unit) Table 51. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2021-2026) Table 55. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2027-2032) Table 56. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 57. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2026) & (K Units) Table 58. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2027-2032) & (K Units) Table 59. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application (2021-2026) Table 60. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application (2027-2032) Table 61. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Application (2021-2026) & (US$/Unit) Table 62. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Application (2027-2032) & (US$/Unit) Table 63. Takeda Pharmaceutical Co., Ltd. Company Information Table 64. Takeda Pharmaceutical Co., Ltd. Business Overview Table 65. Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 67. Takeda Pharmaceutical Co., Ltd. Recent Development Table 68. Shenzhen Salubris Pharmaceuticals Co., Ltd. Company Information Table 69. Shenzhen Salubris Pharmaceuticals Co., Ltd. Business Overview Table 70. Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 72. Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Development Table 73. Sanofi SA Company Information Table 74. Sanofi SA Business Overview Table 75. Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 77. Sanofi SA Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 82. Novartis Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 87. Merck Recent Development Table 88. AbbVie, Inc. Company Information Table 89. AbbVie, Inc. Business Overview Table 90. AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 92. AbbVie, Inc. Recent Development Table 93. Cosette Pharmaceuticals, Inc. Company Information Table 94. Cosette Pharmaceuticals, Inc. Business Overview Table 95. Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 97. Cosette Pharmaceuticals, Inc. Recent Development Table 98. Aurobindo Pharma Ltd. Company Information Table 99. Aurobindo Pharma Ltd. Business Overview Table 100. Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio Table 102. Aurobindo Pharma Ltd. Recent Development Table 103. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2026) & (K Units) Table 106. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2027-2032) & (K Units) Table 107. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 108. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 109. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2026) & (K Units) Table 112. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2027-2032) & (K Units) Table 113. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 114. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 115. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 119. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 120. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 121. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Country (2021-2026) & (US$/Unit) Table 122. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Country (2027-2032) & (US$/Unit) Table 123. United States Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 124. Canada Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 125. Mexico Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 126. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2026) & (K Units) Table 129. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2027-2032) & (K Units) Table 130. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 131. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 132. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2026) & (K Units) Table 135. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2027-2032) & (K Units) Table 136. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 137. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 142. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 143. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 144. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Country (2021-2026) & (US$/Unit) Table 145. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Country (2027-2032) & (US$/Unit) Table 146. Germany Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 147. France Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 148. U.K. Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 149. Italy Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 150. Russia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 151. Spain Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 153. Switzerland Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 154. Sweden Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 155. Poland Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 156. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 157. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 158. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2026) & (K Units) Table 159. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2027-2032) & (K Units) Table 160. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 161. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 162. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 163. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 164. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2026) & (K Units) Table 165. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2027-2032) & (K Units) Table 166. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 167. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2026) & (K Units) Table 171. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2027-2032) & (K Units) Table 172. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 173. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 174. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2026) & (K Units) Table 177. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2027-2032) & (K Units) Table 178. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 179. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 184. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 185. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 186. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Country (2021-2026) & (US$/Unit) Table 187. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Japan Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 189. South Korea Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 190. India Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 191. Australia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 192. Taiwan Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2026) & (K Units) Table 197. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2027-2032) & (K Units) Table 198. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 199. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 200. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2026) & (K Units) Table 203. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2027-2032) & (K Units) Table 204. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 205. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 206. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 210. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021-2026) & (K Units) Table 211. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2027-2032) & (K Units) Table 212. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Country (2021-2026) & (US$/Unit) Table 213. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Brazil Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 215. Argentina Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 216. Chile Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 217. Colombia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 218. Peru Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 220. Israel Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 221. UAE Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 222. Turkey Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 223. Iran Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 224. Egypt Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Angiotensin II Type 1 Receptor (AT1R) Antagonists Distributors List Table 228. Angiotensin II Type 1 Receptor (AT1R) Antagonists Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Angiotensin II Type 1 Receptor (AT1R) Antagonists Image Figure 2. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5mg Image Figure 5. 10mg Image Figure 6. 20mg Image Figure 7. 50mg Image Figure 8. 80mg Image Figure 9. 100mg Image Figure 10. 150mg Image Figure 11. 400mg Image Figure 12. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size Share 2021 VS 2025 VS 2032 Figure 14. Hospital Image Figure 15. Clinic Image Figure 16. Others Image Figure 17. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (2021-2032) & (US$ Million) Figure 19. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Region (2021-2032) Figure 22. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales (2021-2032) & (K Units) Figure 23. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 24. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales YoY (2021-2032) & (K Units) Figure 26. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales YoY (2021-2032) & (K Units) Figure 27. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales YoY (2021-2032) & (K Units) Figure 28. Asia (Excluding China) Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales YoY (2021-2032) & (K Units) Figure 29. South America, Middle East and Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales YoY (2021-2032) & (K Units) Figure 30. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type (2021-2032) Figure 36. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type (2021-2032) Figure 39. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2021-2032) Figure 42. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 43. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application (2021-2032) Figure 45. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Type (2021-2032) Figure 46. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Type (2021-2032) Figure 47. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Application (2021-2032) Figure 48. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Application (2021-2032) Figure 49. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Country (2021-2032) Figure 50. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Country (2021-2032) Figure 51. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Type (2021-2032) Figure 52. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Type (2021-2032) Figure 53. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Application (2021-2032) Figure 54. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Application (2021-2032) Figure 55. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Country (2021-2032) Figure 56. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Country (2021-2032) Figure 57. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Type (2021-2032) Figure 58. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Type (2021-2032) Figure 59. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Application (2021-2032) Figure 60. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Application (2021-2032) Figure 61. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Type (2021-2032) Figure 62. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Type (2021-2032) Figure 63. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Application (2021-2032) Figure 64. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Application (2021-2032) Figure 65. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Country (2021-2032) Figure 66. Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Country (2021-2032) Figure 67. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Type (2021-2032) Figure 68. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Type (2021-2032) Figure 69. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Application (2021-2032) Figure 70. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Application (2021-2032) Figure 71. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Share by Country (2021-2032) Figure 72. SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Share by Country (2021-2032) Figure 73. Angiotensin II Type 1 Receptor (AT1R) Antagonists Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 10mg
  • 20mg
  • 50mg
  • 80mg
  • 100mg
  • 150mg
  • 400mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Takeda Pharmaceutical Co., Ltd.
  • Shenzhen Salubris Pharmaceuticals Co., Ltd.
  • Sanofi SA
  • Novartis
  • Merck
  • AbbVie, Inc.
  • Cosette Pharmaceuticals, Inc.
  • Aurobindo Pharma Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market by Type
  3. 1.2.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5mg
  5. 1.2.3 10mg
  6. 1.2.4 20mg
  7. 1.2.5 50mg
  8. 1.2.6 80mg
  9. 1.2.7 100mg
  10. 1.2.8 150mg
  11. 1.2.9 400mg
  12. 1.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market by Application
  13. 1.3.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Application, 2021 VS 2025 VS 2032
  14. 1.3.2 Hospital
  15. 1.3.3 Clinic
  16. 1.3.4 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Dynamics
  1. 2.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Trends
  2. 2.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Drivers
  3. 2.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Opportunities and Challenges
  4. 2.4 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region
  3. 3.2.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region (2021-2026)
  5. 3.2.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Region (2027-2032)
  6. 3.2.4 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region
  9. 3.4.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region (2021-2026)
  11. 3.4.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Region (2027-2032)
  12. 3.4.4 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Manufacturers
  2. 4.1.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Manufacturers
  6. 4.2.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers, Product Type & Application
  13. 4.7 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market CR5 and HHI
  16. 4.8.2 2025 Angiotensin II Type 1 Receptor (AT1R) Antagonists Tier 1, Tier 2, and Tier 3
5 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market by Type
  1. 5.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type
  2. 5.1.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type
  6. 5.2.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Type (2021-2032)
  9. 5.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Type
6 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market by Application
  1. 6.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application
  2. 6.1.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application
  6. 6.2.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Market Share by Application (2021-2032)
  9. 6.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceutical Co., Ltd.
  2. 7.1.1 Takeda Pharmaceutical Co., Ltd. Company Information
  3. 7.1.2 Takeda Pharmaceutical Co., Ltd. Business Overview
  4. 7.1.3 Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  6. 7.1.5 Takeda Pharmaceutical Co., Ltd. Recent Developments
  7. 7.2 Shenzhen Salubris Pharmaceuticals Co., Ltd.
  8. 7.2.1 Shenzhen Salubris Pharmaceuticals Co., Ltd. Company Information
  9. 7.2.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. Business Overview
  10. 7.2.3 Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  12. 7.2.5 Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments
  13. 7.3 Sanofi SA
  14. 7.3.1 Sanofi SA Company Information
  15. 7.3.2 Sanofi SA Business Overview
  16. 7.3.3 Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  18. 7.3.5 Sanofi SA Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 AbbVie, Inc.
  32. 7.6.1 AbbVie, Inc. Company Information
  33. 7.6.2 AbbVie, Inc. Business Overview
  34. 7.6.3 AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  36. 7.6.5 AbbVie, Inc. Recent Developments
  37. 7.7 Cosette Pharmaceuticals, Inc.
  38. 7.7.1 Cosette Pharmaceuticals, Inc. Company Information
  39. 7.7.2 Cosette Pharmaceuticals, Inc. Business Overview
  40. 7.7.3 Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  42. 7.7.5 Cosette Pharmaceuticals, Inc. Recent Developments
  43. 7.8 Aurobindo Pharma Ltd.
  44. 7.8.1 Aurobindo Pharma Ltd. Company Information
  45. 7.8.2 Aurobindo Pharma Ltd. Business Overview
  46. 7.8.3 Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product Portfolio
  48. 7.8.5 Aurobindo Pharma Ltd. Recent Developments
8 North America
  1. 8.1 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Type
  2. 8.1.1 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2032)
  3. 8.1.2 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2032)
  4. 8.1.3 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Type (2021-2032)
  5. 8.2 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Application
  6. 8.2.1 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2032)
  7. 8.2.2 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2032)
  8. 8.2.3 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Application (2021-2032)
  9. 8.3 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country
  10. 8.3.1 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Type
  2. 9.1.1 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2032)
  3. 9.1.2 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2032)
  4. 9.1.3 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Type (2021-2032)
  5. 9.2 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Application
  6. 9.2.1 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2032)
  7. 9.2.2 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2032)
  8. 9.2.3 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Application (2021-2032)
  9. 9.3 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country
  10. 9.3.1 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Type
  2. 10.1.1 China Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2032)
  3. 10.1.2 China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2032)
  4. 10.1.3 China Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Type (2021-2032)
  5. 10.2 China Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Application
  6. 10.2.1 China Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2032)
  7. 10.2.2 China Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2032)
  8. 10.2.3 China Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Type
  2. 11.1.1 Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2032)
  3. 11.1.2 Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2032)
  4. 11.1.3 Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Type (2021-2032)
  5. 11.2 Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Application
  6. 11.2.1 Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2032)
  7. 11.2.2 Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2032)
  8. 11.2.3 Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Application (2021-2032)
  9. 11.3 Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country
  10. 11.3.1 Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Type
  2. 12.1.1 SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Type (2021-2032)
  5. 12.2 SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Application
  6. 12.2.1 SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Application (2021-2032)
  9. 12.3 SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country
  10. 12.3.1 SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Angiotensin II Type 1 Receptor (AT1R) Antagonists Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Value Chain Analysis
  2. 13.1.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Mode & Process
  6. 13.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Distributors
  9. 13.2.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst